Skip to main content

MARSHALL WACE, LLP

Position in HROW — Harrow, Inc.

CIK 1318757 LONDON, X0

Position in HROW

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$22,739,807
+$12,924,764 QoQ
Shares Held
644,918
+222.0% QoQ
Ownership
1.73%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. HROW ranks #9 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HROW

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $22,739,807 644,918
2025-12-31 $9,815,043 200,307
2025-09-30 $24,481,028 508,116
2025-06-30 $17,251,312 564,876
2025-03-31 $11,429,328 429,674
2024-06-30 $1,112,371 53,249
2023-12-31 $1,271,580 113,534
2023-09-30 $1,783,690 124,126
2023-03-31 $2,108,149 99,629
2022-12-31 $1,505,962 102,030
2022-09-30 $325,877 26,999
2022-06-30 $189,054 25,969
2021-03-31 $197,586 29,272
2020-03-31 $40,847 10,693